Search

Displaying results 6781 - 6790 of 10000 in total
  1. Drug

    Flezurafenib

    go.drugbank.com/drugs/DB21725
    Experimental

    Flezurafenib has a monoisotopic molecular weight of 456.16 Da. … The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.

  2. Drug

    Sembragiline

    go.drugbank.com/drugs/DB20857
    Experimental

    The usage of the INN stem '-giline' in the name indicates that Sembragiline is a monoamine oxydase (MAO)-inhibitor type B. Sembragiline has a monoisotopic molecular weight of 342.14 Da.

  3. Drug

    Mofloverine

    go.drugbank.com/drugs/DB20884
    Experimental

    The usage of the INN stem '-verine' in the name indicates that Mofloverine is a spasmolytic with a papaverine-like action. Mofloverine has a monoisotopic molecular weight of 325.15 Da.

  4. Drug

    Denaverine

    go.drugbank.com/drugs/DB21006
    Experimental

    The usage of the INN stem '-verine' in the name indicates that Denaverine is a spasmolytic with a papaverine-like action. Denaverine has a monoisotopic molecular weight of 383.25 Da.

  5. Drug

    Befetupitant

    go.drugbank.com/drugs/DB21149
    Experimental

    The usage of the INN stem '-pitant' in the name indicates that Befetupitant is a neurokinin NK1​ (substance P) receptor antagonist. Befetupitant has a monoisotopic molecular weight of 565.22 Da.

  6. Drug

    Edonentan anhydrous

    go.drugbank.com/drugs/DB21170
    Experimental

    The usage of the INN stem '-entan' in the name indicates that Edonentan anhydrous is a endothelin receptor antagonist. Edonentan anhydrous has a monoisotopic molecular weight of 536.21 Da.

  7. Drug

    Tuvatidine

    go.drugbank.com/drugs/DB21229
    Experimental

    The usage of the INN stem '-tidine' in the name indicates that Tuvatidine is a histamine- H2​-receptor antagonist, cimetidine derivative. Tuvatidine has a monoisotopic molecular weight of 391.07 Da.

  8. Drug

    Tilsotolimod

    go.drugbank.com/drugs/DB16341
    Investigational

    Tilsotolimod is under investigation in clinical trial NCT03865082 (Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)).

  9. Drug

    EDI-200

    go.drugbank.com/drugs/DB18188
    Investigational

    EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1.

  10. Drug

    Gonyautoxin II

    go.drugbank.com/drugs/DB19186
    Investigational

    Gonyautoxin II is under investigation in clinical trial NCT04799041 (Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study).